CMS's calculation of malpractice data tilts against high-risk specialties, physician organizations say

Why This Topic Matters

The article matters because it highlights how CMS payment methodologies can affect specialty-specific reimbursement, office-administered drugs, geographic payment adjustments, and billing patterns under Medicare. It helps readers understand the types of policy issues being raised during fee schedule comment periods.

Article Sections

1. Malpractice RVU methodology

   Comments from physician organizations on CMS’s approach to malpractice cost calculation and the impact on different specialties are summarized here. The section discusses broader concerns about how the fee schedule reflects risk and premium data.

2. Other recurring topics from comments on the proposed fee schedule

   This section surveys additional issues raised in comments on the proposed 2005 fee schedule. It covers preventive services, drug payment methodology, geographic practice cost adjustments, radiation therapy global period concerns, and ESRD payment questions.

3. New preventive services

   Organizations’ comments on how new Medicare preventive benefits may affect utilization and future payment updates are summarized here.

4. ASP drug payments

   This section addresses comments about the planned drug payment methodology change and related access and reimbursement concerns for physician practices.

5. Geographic Practice Cost Index (GPCI) concerns

   The article summarizes comments about locality payment calculations and concerns that current geographic adjustments do not adequately reflect practice costs.

6. 77427 as a global code

   Comments about CMS’s proposed global period treatment for a radiation therapy code and the resulting billing implications are discussed in broad terms.

7. ESRD

   This section covers comments on ESRD visit-based payment methods and questions about billing for transient patients.